Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "Global Diabetes Devices Market Size, Share & Trends Analysis Report by Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), End-use, Region, and Segment Forecasts, 2024-2030" report has been added to ResearchAndMarkets.com's offering.
The global diabetes devices market size is expected to reach USD 50.33 billion by 2030, registering a CAGR of 7.45% from 2024 to 2030.
The market is primarily driven by factors such as the increasing incidence of diabetes, coupled with technological advancements and innovative product launches. 
Rising adoption of advanced diabetes management solutions in developing regions, government policies, and rising medical tourism are some of the major factors contributing to the market growth. Furthermore, the rising government initiative to spread diabetes awareness and increasing R&D expenditure of major market players are the factors expected to ensure long-term market growth. According to the NCBI report, global health expenditure on diabetes is expected to reach USD 490 billion in 2030 from 376 billion in 2010.
Obesity, sedentary lifestyle, and fast food culture are some of the factors having a significant impact on the market growth. According to Harvard T.H. Chan School of Public Health, the U.S has the highest rates of obesity with every third person being obese and this rate is expected to reach 50% by 2030.
In addition, an increasing number of new market players are transforming the market. New market entrants focus on patient convenience with the help of artificial intelligence technology. They are leveraging technological advancements to improve diabetes care solutions like CGM devices non-invasive insulin delivery systems and digital diabetes management platforms.
Diabetes Devices Market Report Highlights
- North America accounted for the largest share of 38.66% in 2023 owing to favorable reimbursement policies, the presence of key players, and frequent product launches
- By type, the insulin delivery devices market accounted for the largest market size and is also expected to grow at the fastest rate
- By BGM devices, self-monitoring devices are dominating the market owing to their low cost and high usage
- By SMBG devices, testing strips is dominating the market while blood glucose meter is growing at a rapid pace owing to the high adoption of these devices and technological advancement
- By CGM device, the transmitter segment accounted for the largest market share owing to the high cost of devices
- By insulin delivery devices, the pens segment is dominating the market owing to its low cost as compared to other delivery devices and it is also easy to carry and use
- By distribution channels, the hospital pharmacy segment dominated the market 54.3% owing to the rise in sales of diabetes devices in these pharmacies
- By end-use, the Hospital segment accounted for the largest market share of 40.9% owing to improving healthcare infrastructure due to rising investment
- Market leaders are focusing on product launches and technological collaboration.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 195 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $30.31 Billion |
| Forecasted Market Value (USD) by 2030 | $50.33 Billion |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Diabetes Devices Market: Methodology and Scope
Chapter 2. Diabetes Devices Market: Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Diabetes Devices Market: Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing prevalence of obesity and diabetes
3.2.1.2. Technological Innovations & Product Advancements
3.2.1.3. Growing focus on diabetes care
3.2.1.4. Untapped opportunities in developing economies
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulatory policies and regulations
3.2.2.2. High cost of devices
3.3. Diabetes Devices Market Analysis Tools
Chapter 4. Diabetes Devices Market: Type Estimates & Trend Analysis
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Diabetes Devices Market, by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Blood Glucose Monitoring Devices
4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2. Self-Monitoring Devices
4.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.2. Blood Glucose Meters
4.5.2.3. Testing Strips
4.5.2.4. Lancets
4.5.3. Continuous Glucose-Monitoring Devices
4.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3.2. Sensors
4.5.3.3. Transmitters
4.5.3.4. Receiver
4.6. Insulin Delivery Devices
4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.2. Insulin Pumps
4.6.3. Insulin Pens
4.6.4. Insulin Syringes
4.6.5. Insulin Jet injectors
Chapter 5. Diabetes Devices Market: Distribution Channel Estimates & Trend Analysis
5.1. Distribution Channel Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Diabetes Devices Market, by Distribution Channel Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Hospital Pharmacies
5.6. Retail Pharmacies
5.7. Diabetes Clinics/Centers
5.8. Online Pharmacies
5.9. Others
Chapter 6. Diabetes Devices Market: End Use Estimates & Trend Analysis
6.1. End Use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Diabetes Devices Market, by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospitals
6.6. Diagnostic Centers
6.7. Homecare
Chapter 7. Diabetes Devices Market: Regional Estimates & Trend Analysis by Country, Type, Distribution Channel, and End Use
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key Company Market Share Analysis, 2023
8.4. Company Position Analysis, 2023
8.5. Company Categorization (Emerging Players, Innovators, and Leaders)
8.6. Company Profiles
- Medtronic plc
- Abbott Laboratories
- Ascensia Diabetes Care Holdings
- AG F.Hoffmann-La-Ltd
- Dexcom, Inc.
- Bayer AG
- Hoffmann-La Roche Ltd.
- B Braun Melsungen AG
- Lifescan, Inc.
- Dexcom Inc.
- Insulet Corporation
- Ypsomed Holdings
- Companion Medical
- Sanofi
- Valeritas Holding Inc.
- Novo Nordisk
- Arkray, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/dr8xf8
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
